OVERVIEW

We are committed to improving and expanding access to COVID-19 therapeutics for our neighbors that are unequally impacted by pandemic.

The COVID-19 pandemic has worsened existing health inequities in the United States, especially for folks who are low income, over the age of 65, Black, people of color, speak a primary language other than English, or experience visible or invisible disabilities. Systems of power such as racism, classism, misogyny, and xenophobia have caused generational inequities and social determinants of health continually that exclude these folks from fair and just access to healthcare services, and increase their risk of hospitalization and death from COVID-19.  

With reliable and effective treatment available for COVID-19, it’s important we ensure equitable access for all communities. We must invest in serving our neighbors who experience high risk for COVID-19 complications.

Federally qualified health centers (FQHCs) are vital to California’s safety net. One-third of low-income Californians rely on a health center as their primary source of care. These centers and public health systems are well-positioned to connect with patients who test positive for COVID-19 and provide access to treatment. 

Facilitating quick access to COVID-19 therapeutics– including developing test-to-treat pathways within the therapeutic window–  is a complex challenge. Facilitating equitable access for COVID-19 is a major opportunity to work with healthcare providers to establish a stronger foundation for lasting change in California’s safety net system.